a year ago
PACB
AnalystsMatthew SykesMatthew Sykes's Stock Forecasts
AnalystsMatthew Sykes
Analyst Ranking
Top 8%
#367 out of 4868 analysts
Average Return
+9.72%
Win Rate
49%68 out of 138
Risk vs Reward
Poor
Good
Matthew Sykes's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Natera IncNTRA | +200.29% | $40.76 | $122.40 | 2023-10-19 - 2024-10-18 | Strong Buy |
Guardant Health IncGH | +164.71% | $17.06 | $45.16 | 2024-04-14 - 2025-04-14 | Strong Buy |
Natera IncNTRA | +155.84% | $62.64 | $160.26 | 2023-12-28 - 2024-12-27 | Strong Buy |
Natera IncNTRA | +154.88% | $66.00 | $168.22 | 2024-01-29 - 2025-01-29 | Strong Buy |
Natera IncNTRA | +153.09% | $66.41 | $168.08 | 2024-01-28 - 2025-01-28 | Strong Buy |
Matthew Sykes Analyst Color
Get additional color on Matthew Sykes's coverage of popular stocks
a year ago
PACB
2 years ago
DNA
Matthew Sykes's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neogenomics IncNEO | 8 | Strong Buy | $10.00 | +56.37% | Maintains | 16 hours ago |
Revvity IncRVTY | 3 | Strong Buy | $125.00 | +33.79% | Maintains | 2 days ago |
Avantor IncAVTR | 4 | Hold | $14.00 | +7.78% | Downgrades | 2 days ago |
Danaher CorpDHR | 4 | Strong Buy | $240.00 | +20.40% | Maintains | 8 days ago |
Myriad Genetics IncMYGN | 10 | Strong Buy | $14.00 | +88.93% | Maintains | 14 days ago |
Caredx IncCDNA | 10 | Strong Buy | $26.00 | +54.03% | Maintains | 14 days ago |
Icon PLCICLR | 3 | Hold | $200.00 | +32.07% | Downgrades | a month ago |
Charles River Laboratories International IncCRL | 4 | Hold | $170.00 | +43.31% | Downgrades | a month ago |
Fortrea Holdings IncFTRE | 3 | Hold | $11.00 | +76.57% | Maintains | 2 months ago |
Guardant Health IncGH | 13 | Strong Buy | $56.00 | +18.57% | Maintains | 2 months ago |
Genedx Holdings CorpWGS | 13 | Hold | $80.00 | +19.67% | Maintains | 2 months ago |
Pacific Biosciences Of California IncPACB | 5 | Hold | $1.50 | +35.14% | Maintains | 2 months ago |
Natera IncNTRA | 12 | Strong Buy | $190.00 | +25.89% | Maintains | 3 months ago |
Nautilus Biotechnology IncNAUT | 4 | Strong Sell | $1.75 | +153.99% | Downgrades | 5 months ago |
Maravai Lifesciences Holdings IncMRVI | 10 | Strong Sell | $4.25 | +110.40% | Downgrades | 5 months ago |
Veracyte IncVCYT | 5 | Hold | $37.00 | +21.31% | Downgrades | 5 months ago |
Bruker CorpBRKR | 4 | Hold | $60.00 | +49.78% | Upgrades | 5 months ago |
Exact Sciences CorpEXAS | 6 | Strong Buy | $65.00 | +42.42% | Maintains | 6 months ago |
Iqvia Holdings IncIQV | 2 | Strong Buy | $250.00 | +61.22% | Maintains | 6 months ago |
10x Genomics IncTXG | 6 | Strong Sell | $14.00 | +69.29% | Maintains | 6 months ago |
Twist Bioscience CorpTWST | 8 | Strong Buy | $55.00 | +43.53% | Maintains | 10 months ago |
Singular Genomics Systems IncOMIC | 11 | Hold | $6.50 | -67.52% | Maintains | 10 months ago |
Quanterix CorpQTRX | 11 | Strong Buy | $24.00 | +316.67% | Maintains | 10 months ago |
Mettler Toledo International IncMTD | 5 | Hold | $1,300.00 | +21.43% | Maintains | 10 months ago |
Ginkgo Bioworks Holdings IncDNA | 6 | Strong Sell | $12.00 | +62.82% | Maintains | 10 months ago |
Thermo Fisher Scientific IncTMO | 3 | Strong Buy | $640.00 | N/A | Maintains | a year ago |
Cytek Biosciences IncCTKB | 5 | Strong Buy | $10.00 | N/A | Maintains | a year ago |
Agilent Technologies IncA | 4 | Strong Buy | $145.00 | N/A | Maintains | a year ago |
Cue Health IncHLTHQ | 6 | Hold | $0.50 | N/A | Maintains | a year ago |
Invitae CorpNVTAQ | 7 | Strong Sell | $0.50 | N/A | Maintains | 2 years ago |
Lumiradx LtdLMDXF | 2 | Hold | $0.75 | N/A | Maintains | 2 years ago |
Olink Holding Ab OLK | 4 | Hold | $18.00 | N/A | Maintains | 2 years ago |
Zymergen IncZY | 2 | Hold | $12.00 | N/A | Downgrades | 4 years ago |
Quotient LtdQTNTQ | 1 | Hold | $5.00 | N/A | Initiates Coverage On | 4 years ago |
Qiagen NvQGEN | 3 | Hold | $53.56 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.